71 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
;
acting as an administrator of our equity incentive plans;
reviewing and approving, or making recommendations to our Board with respect … to, incentive compensation and equity plans;
reviewing and recommending that our Board approve the compensation for our Chief Executive Officer and Executive
S-8
EX-5.1
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Registration of securities for employees
4:34pm
stock of the Company, par value $0.0001 per share (the “Shares”), issuable under the Company’s 2023 Incentive Award Plan (the “2023 Plan”) and 2023
S-8
i670uwc8zsg at
7 Mar 24
Registration of securities for employees
4:34pm
S-8
6kbdh7j
7 Mar 24
Registration of securities for employees
4:34pm
S-8
EX-23.2
1r63i7e2ecq
7 Mar 24
Registration of securities for employees
4:34pm
10-K
EX-10.23
jy42skm o6h7zxjr
7 Mar 24
Annual report
4:05pm
10-K
EX-10.22
2fi54d7
7 Mar 24
Annual report
4:05pm
10-K
EX-97.1
sey2ta34l05qrmy
7 Mar 24
Annual report
4:05pm
10-K
EX-23.1
bjspbvps1e4yp
7 Mar 24
Annual report
4:05pm
10-K
tj5vqpur4e m2svx94pb
7 Mar 24
Annual report
4:05pm
10-Q
v9yxlx
1 Nov 23
Quarterly report
4:05pm
S-8
EX-99.1
ng3m37z4srm7a cqjqel
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-23.2
scoivst2p
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-99.3
s9uqt h2cuo909aley8
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-99.4
s2g8m0b
19 Sep 23
Registration of securities for employees
9:57pm
S-8
rx1 lkqf1w8vt17
19 Sep 23
Registration of securities for employees
9:57pm
S-8
hsso6le1
19 Sep 23
Registration of securities for employees
9:57pm